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Introduction: Developing cartilage constructs with injectability, appropriate matrix composition and persistent
cartilaginous phenotype remains an enduring challenge in cartilage repair. Bone marrow derived mesenchymal stem cells
(BMSCs) have chondrogenic potential. Current approaches to drive their chondrogenic differentiation require extensive
cell manipulation ex vivo and using exogenous growth factors. However, preventing hypertrophic transition of BMSCs
in vivo and maintaining persistent chondrogenesis remain bottlenecks in clinical application. This study aimed to develop
completely biological, injectable constructs to generate cartilage by co-transplanting chondrocyte and BMSCs.
Methods: We fabricated fragmented chondrocyte macroaggregate (cell bricks) and mixed them with platelet rich
plasma (PRP); BMSCs were mixed into the above constructs, allowed to clot and then subcutaneously injected into
nude mice. Gross morphology observation, histological and immunohistochemical assay, immunofluorescence assay,
biochemical analysis and gene expression analysis were used to compare the properties of BMSC-cell bricks-PRP
complex with BMSC in PRP or BMSC/chondrocytes in PRP.
Results: The constructs of BMSCs-cell bricks-PRP that were subcutaneously injected resulted in persistent chondrogenesis
with appropriate morphology, adequate central nutritional perfusion without central necrosis or ossification, and further
augmented nasal dorsum without obvious contraction and deformation.
Conclusions: We concluded that cell bricks-enriched PRP clotting provides an autologous substance derived niche for
chondrogenic differentiation of BMSCs in vivo, which suggests that such an injectable, completely biological system is a
suitable stem cell carrier for micro-invasive cartilage repair.Introduction
Chondrogenesis is the process by which cartilage is formed
from condensed mesenchyme tissue. During the process,
condensing mesenchyme expresses various extracellular
matrix (ECM) and signaling molecules, which drives the
compaction of mesenchymal cells, shaping of the condensa-
tions and chondrogenic differentiation of cells [1,2]. For
therapeutic cartilage regeneration, harvesting bone marrow-* Correspondence: zhaoym@fmmu.edu.cn; wuweidds@126.com
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unless otherwise stated.derived mesenchymal stem cells (BMSCs) and reconstituting
them using three-dimensional culture systems have been ex-
tensively studied for recapitulating chondrogenesis [3].
Among various approaches, injection of biomaterials
loaded with BMSCs into the defect site is highly desirable
for cartilage repair because such a procedure is micro-
invasive and grafts are more flexible to fill the lesions with
various shapes [4,5]. However, preventing the hyper-
trophic transition of BMSCs and morphological contrac-
tion in vivo still presents significant challenges in
injectable graft [6].
The addition of multiple growth factors, such as trans-
forming growth factor beta, insulin-like growth factor 1
and fibroblast growth factor 2, into the medium induces
robust chondrogenesis of BMSCs in vitro [7,8], whereasis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hypertrophy and ossification replicating only the process
of endochondral ossification [9]. In contrast, mature chon-
drocytes cultured within low passages regenerate cartilage
with a stable phenotype ectopically. Further attempts to co-
culture BMSCs and chondrocytes in polymeric scaffolds re-
vealed that chondrocytes induce chondrogenesis of BMSCs
and prevent hypertrophic transition of differentiated
BMSCs via secreting paracrine signals [10]. Additionally,
cartilaginous ECMs produced by chondrocytes direct phys-
ical cell–matrix interaction and tether secretory growth
factors with glycosaminoglycans, thus benefiting chondro-
genesis of BMSCs [11,12]. Incorporation of chondrocytes
into the injectable grafts is therefore a promising approach
to construct the chondrogenic niche and enable the stable
chondrogenesis of BMSCs.
Platelet-rich plasma (PRP) extracted from blood provides
an autologous source of various growth factors; moreover,
the incomparable biocompatibility and thrombin-stimulated
clotting enabled PRP to be a promising cell carrier for tissue
engineering [13]. Unfortunately, owing to poor mechanical
stability and rapid degradability, direct mixing of chondro-
cytes with PRP leads to shrinking and deformed cartilage
formation in vivo [14]. Combining chondrocytes and self-
produced cartilaginous ECM during in vitro graft construc-
tion not only significantly enhances the morphological
stability of grafts in vivo, but also carries multiple angiogenic
inhibitors such as endostatin and chondromodulin I [15,16];
vascular infiltration-mediated ossification is therefore ex-
pected to be prevented. In a previous study we developed
the cell bricks technique, which cultured a chondrocyte
sheet and cut such a cell–ECM complex into multiple small
fragments (cell bricks). We found that chondrocyte bricks
significantly inhibited vascular infiltration into PRP gels and
slowed their degradation, thus maintaining the framework
and shape of the PRP grafts [17]. We hypothesized that the
cell brick-enriched PRP gel could be an ideal injectable niche
for BMSCs, which is expected to regenerate biological cartil-
age tissues with persistent cartilaginous phenotype, less de-
formation and uniform histological structure. In this study,
we investigated the in vivo performance of BMSCs in cell
brick-enriched PRP gels, and examined the mechanism of
stable chondrogenic differentiation of BMSCs in such an in-
jectable niche.
Materials and methods
Animals and experimental design
This animal experiment was approved by the Institutional
Animal Care and Use Committee of the Fourth Military
Medical University, Xi’an, PR China; the operative proced-
ure and care of the mice were performed in accordance
with the institutional guidelines of the committee. Forty-
eight nude mice (6 weeks old, male, 24 to 28 g in weight)
were used for the experiment. The mice were acclimatedfor 1 week before operation and monitored for general ap-
pearance, activity, excretion and weight. They were then
randomly divided into three groups (n = 12 in each group):
BMSCs–PRP (B-P) group, BMSCs–chondrocytes–PRP (B-
C-P) group and BMSCs–cell bricks–PRP (B-CB-P) group.
The animals were sacrificed for sample harvest at 4-week
and 12-week time points (n = 6 at each time point). In
addition, a chondrocytes–chondrocyte bricks–PRP (C-
CB-P) group was used as a control group to evaluate the
chondrogenesis through 12 weeks (n = 6), and a nasal aug-
mentation group was used for functional tests (n = 6).
Cell isolation
BMSCs were harvested and isolated from the tibiae and
femora of 4-week-old New Zealand rabbits sacrificed by
injecting overdoses of pentobarbital. After being physically
disrupted, bone marrow was washed out from the frag-
ments with 40 ml Dulbecco’s modified Eagle’s medium
(DMEM; Hyclone, Logan City, Utah, USA) and centrifuged
at 1,500 rpm for 5 minutes. The supernatant was removed
and the cells were twice washed with phosphate-buffered
saline (PBS) and then resuspended in DMEM low glucose
supplemented with 10% fetal bovine serum (Hyclone),
50 μg/ml penicillin and 30 μg/ml streptomycin (Amresco,
Cleveland, Ohio, USA). Primary cells were seeded in a
75 cm2 culture flask at 5 × 105 nucleated cells/cm2 in
DMEM low glucose supplemented with 10% fetal bovine
serum (Hyclone), L-glutamine (272 μg/ml; Amresco),
ascorbate-2-phosphate (50 μg/ml; Sigma, St. Louis, MO,
USA), 50 μg/ml penicillin and 30 μg/ml streptomycin
(Amresco) (medium I) and incubated at 37○C with 5% car-
bon dioxide. After 3 days, the nonadherent cells were re-
moved during the first media change. Remaining adherent
cells were further cultured with a medium change every
3 days. The adherent cells were incubated until cell clones
reached over 80% confluence and then were digested with
0.25% trypsin (Hyclone) and subcultured at 1.0 × 104 cells/
cm2. Passage 1 cells were used for further experiments.
Auricular chondrocytes were isolated from the ears of 4-
week-old New Zealand rabbits as described previously [14].
Briefly, one-half of the primary chondrocytes were cultured
in 25 cm2 culture flasks at 1.5 × 105 cells/cm2 in medium I
to enhance proliferation for 10 days. The other half of the
isolated primary chondrocytes were cultured at 6.5 × 105
cells/cm2 in six-well plates in DMEM high glucose supple-
mented with 20% fetal bovine serum (Hyclone), L-glutamine
(272 μg/ml; Amresco), ascorbate-2-phosphate (50 μg/ml;
Sigma), 50 μg/ml penicillin and 30 μg/ml streptomycin
(Amresco) (medium II) and incubated at 37○C with 5% car-
bon dioxide. At day 10 when the solid white membrane of
chondrocytes formed, the membranes were fragmented in a
homemade cutting system in order to achieve cell bricks as
described previously with some modification [17]. Briefly,
after the cell sheet formed in the Petri dish, it was scratched
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solution of calcium chloride (102 mM) was then carefully
dropped into the dish until the alginate solution turned into
gel completely. The homemade cutting device is mainly
composed of 20 multiple blades (Figure 1B), and the dis-
tance between each blade is 1 mm. The chondrocyte sheet–
gel complex was then cut via compressing the cutting device
vertically and horizontally. We always made gel 3 to 5 mm
in thickness; then fragmented gel–cell complexes could be
obtained without rolling up, and further were immersed into
dissolving buffer (55 mM sodium citrate (Sigma) and
0.15 M sodium chloride (Sigma), pH 6.8) – thereafter, cell
bricks were released.
Preparation of platelet-rich plasma
Whole blood was aspirated from rabbit (New Zealand
white rabbits weighing 2.5 to 3.0 kg) ventricle after
anesthesia and was mixed with sodium citrate (3.8%) at
a ratio of 9:1 for anti-coagulation. PRP was enriched by
a two-step centrifugation process as described elsewhere.
Briefly, 18 ml whole blood was drawn from the ventricleFigure 1 Characterization of cell bricks and injectable cell brick–platele
chondrocyte bricks and in vivo cell implantation. A chondrocyte sheet was cu
system (by multiple blades) (B.a, b, c). The thickness of the cell brick is about 5
we used a stereomicroscope to measure the cell brick, which was 1,032 μm×
cell bricks or chondrocytes and cultured bone marrow-derived mesenchymal ste
platelet-rich plasma (PRP), so that the injectable constructs were formed and inje
B-CB-P, BMSCs–cell bricks–PRP; B-P, BMSCs–PRP. (D) The graft maintained structu
40. (a) Scanning electron microscopy images showed BMSCs distributed even
week postoperatively, 5-bromo-2-deoxy uridine-labeled BMSCs (arrowheads) still
magnification, bar = 200 μm; d: high magnification, bar = 50 μm). Labeled BMSCs
staining and immunohistochemistry staining of collagen II (D.e, f).of each rabbit into two sterile tubes, each containing
1 ml sodium citrate (3.8%) solution as an anticoagulant.
The tubes were then spun at 1,800 rpm for 8 minutes in
a centrifuge at room temperature, and the blood sepa-
rated into three phases: platelet-poor plasma (top), PRP
(middle), and erythrocytes (bottom). The top and middle
layers were transferred to new tubes and centrifuged
again at 3,600 rpm for 8 minutes. The supernatant
plasma was discarded, and the remaining 2 ml plasma
containing precipitated platelets was blended evenly and
designated PRP. The final platelet concentration was ad-
justed to 20.9 ± 1.1 × 108/ml. PRP was preserved on ice
for further steps.
Preparation and transplantation of constructs
A sample of 500 μl PRP was used per animal. BMSCs,
chondrocytes and cell bricks were collected and rinsed
with PBS once. For the B-P group, BMSCs (2.25 × 107
cells) were centrifuged and then suspended with PRP so-
lution. For the B-C-P group, BMSCs (2.25 × 107 cells)
and chondrocytes (7.5 × 106 cells) were centrifuged intot-rich plasma gel. (A), (B) Schematic description of the strategy for
ltured, harvested and embedded to be fragmented in a net cutting
0 to 80 μm; bar = 50 μm, magnification × 200 (B.c2, c3). Moreover,
1,016 μm; bar = 200 μm, magnification × 30 (B.c1). (C) The obtained
m cells (BMSCs) mixed together or BMSCs alone were suspended in
cted subcutaneously into nude mice. B-C-P, BMSCs–chondrocytes–PRP;
ral integrity at the fourth week postoperatively; bar = 200 μm, magnification ×
ly in the spaces formulated by chondrocyte bricks. (b) Even at the 12th
occupied these spaces and further differentiated into tissues (c: low
differentiated into newborn chondrocytes characterized by safranin-O
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the B-CB-P group, BMSCs (2.25 × 107 cells) and cell
bricks (from 7.5 × 106 primary cells) were centrifuged into
a mixing pellet and resuspended with PRP sufficiently. For
the C-CB-P group, chondrocytes (2.25 × 107 cells) and cell
bricks (from 7.5 × 106 primary cells) were centrifuged into a
mixing pellet and resuspended with PRP sufficiently. The
injecting process was performed with the following proced-
ure: PRP–cellular components were aspirated into a 2 ml
syringe. The syringe was then aspirated with 50 μl
thrombogenic agent (100 U/ml in 100 mg/ml calcium
chloride; Villalba, Madrid, Spain Biomedical) and mixed.
After being anesthetized with ethyl ether, the clotting con-
structs were injected subcutaneously into the dorsum of
nude mice via a 16 G needle, and the construct turned into
gel-like spheroid instantly after the mouse received it. An
animal functional model was also constructed by subcuta-
neously injecting 300 μl B-CB-P components fabricated
with same method as above into the nasal dorsum of nude
mice. To characterize the cell bricks enriched with PRP gel,
some pieces of complex were fixed in 2.5% glutaraldehyde,
and then processed for scanning electronic microscopy (Jeol
JSM6330F; Akishima, Tokyo Japan) examination.
Gross morphology
After 4 weeks and 12 weeks, animals were euthanized and
the samples were dissected from the surrounding tissues.
Wet weights, thicknesses and volumes of the constructs
were measured as described before [17]. Specimens were
evaluated for contour deformation, including the constructs
for functional experiment.
Biochemical analysis (glycosaminoglycan quantification
and collagen quantification)
Sulfated glycosaminoglycans (sGAGs) were determined for
specimens using a Blyscan™ sGAG Assay Kit (B1000; Bioco-
lor, Carrickfergus UK). sGAG was extracted from specimens
by mincing the specimen into tiny pieces and digesting with
papain extraction reagent (Sigma) at 65○C for 18 hours. The
kit instructions were used to measure the sGAG concentra-
tion in the supernatant. sGAG per wet weight construct was
calculated from the sGAG standard curve. Collagen content
was quantified using a Sircol™ Collagen Assay (S1000; Bioco-
lor). Collagen was extracted from specimens by mincing
specimen segments into pieces of about 1 mm3 and digest-
ing with pepsin (1 mg/ml suspended in 0.5 M acetic acid;
Santa Ana, California, USA MP). The kit instructions were
used to measure the collagen concentration in the super-
natant. Total collagen per construct wet weight was calcu-
lated from the collagen standard curve.
Histological and immunohistochemical assay
Samples were fixed in 4% paraformaldehyde and embed-
ded in paraffin and then cut into 8 um sections. Sectionswere stained with hematoxylin and eosin (H & E), safranin-
O, Masson trichrome or Von Kossa. To investigate the ex-
pression of type I, type II and type X collagen in matrices
and vascular endothelial growth factor (VEGF), some
sections were processed for two-step indirect immunohisto-
chemical staining as studied previously [17]. Briefly, expres-
sion of type I collagen, type II collagen, type X collagen and
VEGF was detected using primary anti-collagen type I anti-
body (mouse anti-rabbit, 1:50; Abcam, Cambridge, MA
USA), anti-collagen type II antibody (mouse anti-rabbit,
1:50; Acris, Herford Germany), anti-collagen type X anti-
body (mouse anti-rabbit, 1:50; Abcam) and anti-VEGF anti-
body (mouse anti-rabbit, 1:50; Abcam), followed by
horseradish peroxidase-conjugated anti-mouse antibody
(1:200 in PBS; Santa Cruz Dallas, Texas, USA) and color de-
velopment with diaminobenzidine tetrahydrochloride (Santa
Cruz).
BrdU and CD31 immunofluorescence assay
To determine the origin of new-born chondrocytes, 5-
bromo-2-deoxy uridine (Brdu) was used to label BMSCs in
the B-CB-P group. After 12 weeks, specimens were har-
vested and fixed in 4% paraformaldehyde overnight before
creating frozen sections. The sections were permeabilized
with 0.3% Triton X-100 at room temperature for 20 minutes.
After being rinsed three times in PBS for 10 minutes, the
samples were blocked with 5% goat serum for 20 minutes at
room temperature. The samples were then incubated with
primary anti-BrdU antibody (rat monoclonal, 1:100; Abcam)
at 4°C overnight. After being rinsed three times in PBS for
10 minutes and incubated with Cy3-AffiniPure conjugated
secondary antibody (goat anti-rat, 1:100; Jackson West
Grove, PA America) at room temperature for 2 hours, the
sections were incubated with DAPI for 5 minutes. Finally,
the sections were washed three times in PBS for 10 minutes,
covered with a coverslip and studied under a fluorescent
microscope (Olympus IX71; Tokyo Japan).
The protocol of CD31 immunofluorescence assay for the
B-CB-P group samples at 4 weeks and 12 weeks was the
same as the Brdu immunofluorescence assay. Primary anti-
CD31 antibody (mouse anti-rabbit, 1:100; Abcam) was
incubated at 4°C overnight, followed by Cy3-AffiniPure con-
jugated secondary antibody (goat anti-mouse, 1:100; Jackson
America).
RNA isolation and real-time RT-PCR
Total RNA from rabbit auricular cartilage and different
groups was extracted by RNAiso Plus (TaKaRa, Shiga Japan)
followed by a one-step phenol chloroformisoamyl alcohol
extraction, as described by the manufacturer’s protocol.
Real-time RT-PCR analysis of five genes – VEGF, collagen
(COL)-I, COL-II, COL-X and GAPDH – was performed
using the One Step SYBR® PrimeScript™ RT-PCR Kit
(TaKaRa). The primer sequences used in this study are












COL, collagen; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; VEGF,
vascular endothelial growth factor.
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times. The results are presented as target gene expression
first normalized to GAPDH in the same sample (ΔCt), and
then to the expression of that target gene measured in rabbit
auricular cartilage as native control (ΔΔCt). The 2–ΔΔCt
method was used to compare differences of gene expression
among the three groups.
Data analysis
All results are expressed as the mean ± standard deviation.
Statistical analyses were performed using SPSS 17.0 soft-
ware (SPSS, Chicago, IL, USA). Analysis of variance was
used for multiple group comparisons, followed by Tukey’s
honestly significant difference tests; P <0.05 was consid-
ered to indicate statistical significance.
Results
Characterization of cell bricks and injectable cell
brick–platelet-rich plasma gel
At the end of the culture, the seeded chondrocytes
produced sufficient ECM and transformed into semi-
transparent white membrane (Figure 1B.a). After cutting
with the homemade cutting device, square fragments of size
1 mm2 (Figure 1B.c1) as characterized by stereomicroscope
were produced so that they could pass through a 16 G nee-
dle smoothly. For histological analysis of cell bricks,
safranin-O staining was performed and showed that a large
amount of glycosaminoglycan (GAG) occupied the extra-
celluar space, which confirmed formation of cartilaginous
ECM (Figure 1B.c3). Before injecting cellular constructs,
mixing cell bricks with PRP and then clotting resulted in
morphologically stable blocks, which also efficiently main-
tained spheroid morphology subcutaneously after injection
(Figure 1C). We further examined constructs 4 weeks after
they were injected in vivo (Figure 1D). H & E staining
showed chondrocyte bricks distributed evenly and support-
ing the constructs, spindle cells filling into the spacesamong bricks (Figure 1D.a). Scanning electron microscopy
images confirmed the observation from H & E images, and
proved that chondrocyte bricks perform as a framework in-
side the PRP gel, and form multiple, enclosed cavities pre-
pared for BMSC filling (Figure 1D.b). Brdu immunostaining
confirmed that spindle cells filling in spaces among bricks
were implanted BMSCs (Figure 1D.c, d); these cells consist-
ently existed even after 12 weeks postoperatively, and
presented as newborn chondrocytes characterized with
safranin-O staining, thus constituting most of the newly
formed cartilage among cell bricks (Figure 1D.e, f).
Cell brick-enriched platelet-rich plasma gel guided
chondrogenesis of BMSCs with minimal deformation and
contraction
From the fourth week, observable knobbles could be
detected in all animals. Gross morphology revealed that
B-CB-P and B-C-P grafts transformed into tissues with
white, pearly, opalescent appearance at both time points
(Figure 2A,D), whereas the B-P group turned into vas-
cularized and calcified tissues (Figure 2C). As compared
with constructs injected instantly, the B-C-P and B-P
groups contracted significantly after the fourth week
(Figure 2B,C), characterized by compressed, irregular
outline and uneven thickness throughout samples.
In contrast, cell brick-enriched constructs (B-CB-P)
significantly resisted in vivo contraction (Figure 2A).
After 12 weeks, the B-CB-P group maintained their ori-
ginal morphology and presented a resilient property
(Figure 2D), whereas B-C-P further turned into harder
tissues and contracted more (Figure 2E). Moreover, the
B-P knobbles were largely absorbed and almost disap-
peared subcutaneously at this time (Figure 2F). In order
to quantitatively evaluate the roles of cell bricks in the
resistance of graft shrinkage and deformation, we mea-
sured the volumes, thicknesses and wet weights of
regenerated tissues after 4 weeks and 12 weeks postop-
eratively. As Figure 2G,J shows, wet weight measurement
of all samples showed significant differences among groups
(4 weeks: n = 6, F= 520.9, P < 0.0001; 12 weeks: n = 6,
F= 3,601, P <0.0001). After 4 weeks, B-CB-P (351.7 ±
27.2 mg) was significantly larger than B-P (49.1 ± 4.7 mg,
P <0.01) and B-C-P (115.2 ± 10.9 mg, P <0.01). After
12 weeks, B-CB-P (356.9 ± 10.2 mg) was significantly larger
than B-P (5.6 ± 0.5 mg, P < 0.01) and B-C-P (96.7 ± 7.2 mg,
P <0.01). Accordingly, volume measurements also indicated
significant differences among the groups (4 weeks: n = 6,
F= 572.6, P <0. 0001; 12 weeks: n = 6, F= 4,267, P <0. 0001).
As Figure 2H shows, the volume of the B-CB-P group
(388.6 ± 28.6 μl) was significantly higher than those of
the B-P (85.6 ± 6.3 μl, P <0.01) and B-C-P (96.1 ±
8.5 μl, P <0.01) groups. After 12 weeks (Figure 2K),
the volume of the B-CB-P group (396.6 ± 10.5 μl) was
significantly higher than those of the B-P (5.0 ± 0.3 μl,
Figure 2 Macroscopic examination of regenerated tissue form grafts. Close macroscopic views of the regenerated cartilage from the B-CB-P (A, D),
B-C-P (B, E) and B-P (C, F) groups after 4 and 12 weeks of in vivo incubation. Samples harvested from mice at 4 weeks (G, H, I) and 12 weeks (J, K, L)
postoperatively present different volume, weight and thickness. **P <0.01. B-C-P, BMSCs–chondrocytes–PRP; B-CB-P, BMSCs–cell bricks–PRP; B-P, BMSCs–PRP;
BMSC, bone marrow-derived mesenchymal stem cell; PRP, platelet-rich plasma.
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over, the thickness of the samples are significantly differ-
ent after 4 weeks (n = 6, F = 228.3, P <0. 0001) and
after 12 weeks (n = 6, F = 549.0, P <0. 0001); at
4 weeks, the thickness of the B-CB-P group (3.9 ±0.2 mm) was significantly higher than those of the B-
P (2.0 ± 0.2 mm, P <0.01) and B-C-P (3.0 ± 0.1 mm,
P <0.01) groups (Figure 2I). At 12 weeks (Figure 2L),
the thickness of the B-CB-P group (3.7 ± 0.2 mm,) was sig-
nificantly higher than those of the B-P (1.0 ± 0.1 mm,
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above results suggest that cell bricks play an important
role in the maintenance of morphology.
Cell-bricks guided persistent ectopic chondrogenesis of
BMSCs and prevented ossification
The cartilaginous characters of regenerated tissue were
examined by safranin-O staining and type II collagen im-
munostaining, which further revealed different remodeling
processes in vivo and different histological structures of
engineered tissues. Following 4 weeks in vivo, in the B-P
group BMSCs developed into cancellous bone (Figure 3I),
and after 12 weeks these samples were almost completelyFigure 3 Cell brick-enriched platelet-rich plasma gel guided chondrogene
chondrogenesis of grafts in vivo at 4 weeks (A to L) and 12 weeks (M to X). Mer
tissue formation throughout the graft (A, E, M, Q), while the C-CB-P group accom
differentiation in BMSC regions, as confirmed by hematoxylin and eosin (HE), Safr
formation from chondrocyte transplantation (V, W, X). In contrast, progressive ost
bar = 2 mm, magnification × 40 (A, E, M, Q, U); bar = 1 mm, magnification × 40(I);
X). B-C-P, BMSCs–chondrocytes–PRP; B-CB-P, BMSCs–cell bricks–PRP; B-P, BMSCs–
PRP, platelet-rich plasma.absorbed (data not presented). We then used C-CB-P as a
control group for evaluation of long-term chondrogenesis
(Figure 3U). Samples from the B-CB-P and B-C-P groups
presented tissue formation throughout the grafts, in con-
trast with central necrosis in the C-CB-P group, and cell
survival and tissue development could be observed in the
interior of these grafts. In B-C-P samples, two distinct
tissue regions were presented: cell bricks derived cartil-
aginous tissue that was strongly positive for GAG stain-
ing, and BMSCs derived ossifying ECM (Figure 3E,F,G).
Furthermore, 12 weeks of in vivo incubation resulted in
cancellous bone and mature cartilaginous matrices from
chondrocyte bricks. Surprisingly, no calcification andsis of bone marrow-derived mesenchymal stem cells. Examining
ged images showed the B-CB-P and B-C-P groups acquired cell survival and
panied central necrosis (U). The B-CB-P group presented chondrogenic
anin-O and COL-II immunostaining (B, C, D; N, O, P), which is close to tissue
eogenesis occurred in the B-C-P and B-P groups (F, G, H; R, S, T; J, K, L);
bar = 50 μm, magnification × 200 (B, C, D, F G, H, J, K, L, N, O, P, R, S, T, V, W,
PRP; BMSC, bone marrow-derived mesenchymal stem cell; COL, collagen;
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group through 4 weeks of in vivo incubation. Instead,
regions with typical cartilage morphology – that is,
round cells with lacunae surrounded by ECM – were
found sparsely distributed inside the formed tissues
(Figure 3A,B,C,D). In vivo incubation through 12 weeks
allowed merging of cartilaginous regions and emergence
of cartilage shell in the B-CB-P group (Figure 3M); the
BMSCs in this group continuously turned into round cells
with lacunae surrounded by more cartilaginous matrix,
which was characterized by deepening safranin-O staining
and COL-II immunostaining (Figure 3N,O,P).
Just as Figure 4I-J,K,L shows, ossification is always an im-
portant issue that hinders application of BMSC ectopic
chondrogenesis. Von-Kossa staining revealed that calcium
shown as black-colored crystals deposited widely and hyper-
trophic transition rapidly occurred in the B-P group.
Calcium deposits could also be found in the B-C-P group as
early as 4 weeks postoperatively (Figure 4I-E), and sig-
nificantly more calcium could be found at 12 weeks
(Figure 4II-E), which confirmed osteogenesis of BMSCs
in this group. Masson’s trichrome staining of samples
demonstrated production of mature collagen in the B-
C-P and B-P groups, which confirmed formation of ma-
ture bone (Figure 4I-F,J,II-F). In contrast, no calcium
deposition and cartilaginous collagen production were
shown in the B-CB-P group through 4 weeks and
12 weeks (Figure 4I-A,B,II-A,B), which is in accordance
with the chondrocyte implantation group (Figure 4II-I,J)
and thus presented chondrogenic performance. To fur-
ther identify the hypertrophic transition of implanted
BMSCs in different groups, type I and type X collagen
immunostaining were performed. In accordance with
histological examination, BMSCs in the B-C-P group
started to express type I collagen and type X collagen
around cells (Figure 4I-G,H) at the fourth week, and the
newly formed ECM presented deeper staining for the
above proteins through 12 weeks (Figure 4II-G,H), indi-
cating that these cells underwent progressively hyper-
trophic transition. In contrast, BMSCs in the B-CB-P
group maintained low-level staining of type I and type X
collagen (Figure 4I-C,D;II-C,D), even after 12 weeks
in vivo; the staining of both collagens was still signifi-
cantly fainter than for B-C-P samples, which is similar
with staining in the chondrocyte implantation group
(Figure 4II-K,L).
We monitored the transcript levels of Col-I, Col-II
and Col-X of cells within the B-CB-P, B-C-P and B-P
groups and native cartilage (Figure 5A,B,C,D,E,F).
Figure 5B shows that the expression levels of Col-II
genes in the B-CB-P group were significantly higher
than in the B-P and B-C-P groups and even similar to
native cartilage tissues (P <0.05). Furthermore, 12-week
samples presented consistent Col-II expression in theB-CB-P group (Figure 5E). In contrast, hypertrophic
markers such as Col-I and Col-X expression were sig-
nificantly higher in the B-P and B-C-P groups through
12 weeks (Figure 5A,C,D,F; P <0.05). These results con-
firmed histological observations and suggested that
chondrocyte bricks are more efficient in promoting
chondrogenic differentiation of BMSCs than chondro-
cytes. Quantification of collagen and GAG within sam-
ples revealed significant differences among groups
(4 weeks, n = 5: collagen, F = 210.5, P <0.0001; sGAG,
F = 117.2, P <0.0001; 12 weeks, n =5: collagen, F = 36.54,
P <0.0001; sGAG, F = 115.5, P <0.0001). After 4 weeks,
the B-CB-P group presented the highest collagen
content and GAG content (collagen, 1.22 ± 0.08 μg/mg;
sGAG, 14.26 ± 1.26 μg/mg); although significantly lower
than those in native cartilage (collagen, 1.95 ± 0.10 μg/mg;
sGAG, 18.64 ± 1.66 μg/mg) (P <0.05), they were signifi-
cantly higher than those in B-C-P group (collagen, 0.92 ±
0.06 μg/mg; sGAG, 11.68 ± 0.86 μg/mg) (P <0.05)
(Figure 5C). After 12 weeks, the B-CB-P group presented
the highest amount of collagen content and GAG content
(1.60 ± 0.11 μg/mg; sGAG, 17.29 ± 1.13 μg/mg), although
it is significantly lower than those in native cartilage (colla-
gen, 2.11 ± 0.20 μg/mg; sGAG, 19.62 ± 1.31 μg/mg) (P
<0.05), it was significantly higher than those in the B-C-P
group (collagen, 0.43 ± 0.02 μg/mg; sGAG, 10.30 ± 0.82 μg/
mg) (P <0.05) (Figure 5D).
Angiogenesis regulated by cell bricks prevented central
necrosis and ossification of constructs
Nutritional perfusion determined survival of trans-
planted cells, especially for those in the interior of grafts.
Histological examination revealed that cell brick-
enriched PRP gel mixed with chondrocytes resisted graft
contraction whereas it cannot support chondrocyte sur-
vival in the central part of grafts, thus causing central
necrosis and formation of the central cavity (Figure 3U).
Surprisingly, both B-C-P and B-CB-P grafts presented
complete cellularization and tissue formation through-
out grafts, but no central necrosis was observed in these
samples. Especially for tissue formed in the B-CB-P
group, both cell bricks and BMSCs maintained cell
morphology and presented progressive chondrogenesis.
Higher magnification displayed that circular, capillary-
like tissues formed in BMSC regions of grafts as early as
the fourth week. CD31 immunostaining (Figure 6A,B)
confirmed that such a structure is constituted with
endothelial cells, thus proving that BMSC regions per-
mitted early vascular infiltration and nourished central
tissues. Furthermore, we compared the number of blood
vessels at the fourth week and 12th week (Figure 6C,D)
by counting CD31-positive blood vessels and measuring
their area according to a previously published procedure
[18]. The average number of blood vessels at the fourth
Figure 4 Cell bricks guided persistent ectopic chondrogenesis of bone marrow-derived mesenchymal stem cells and prevented ossification.
Examining osteogenesis of grafts in vivo at 4 weeks (I-A to I-L) and 12 weeks (II-A to II-L). The B-CB-P group did not present ossification of BMSCs
through 12 weeks (I-A to D; II-A to D), as confirmed by Von-Kossa, Masson’s trichrome, COL-I and COL-X immunostaining, which is similar to the chondrocyte
implantation group (II-I to L). In contrast, BMSCs in the B-C-P group presented slower calcification than the B-P group (I-E to H, I-I to L), whereas final
ossification occurred through 12 weeks (II-E to H); bar = 50 μm, magnification × 200 (I-A to L, II-A to L). B-C-P, BMSCs–chondrocytes–PRP; B-CB-P, BMSCs–cell
bricks–PRP; B-P, BMSCs–PRP; BMSC, bone marrow-derived mesenchymal stem cell; COL, collagen; PRP, platelet-rich plasma.
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Figure 5 Chondrogenesis-related gene expression and quantifications of glycosaminoglycan and collagen. Real-time RT-PCR of samples at the
fourth week (A, B, C) and 12th week (D, E, F) revealed the expression of Col-I, Col-II and Col-X in the cells of different groups which were all normalized to
rabbit auricular cartilage. *Statistically significant difference from rabbit auricular cartilage (P <0.05). #Statistically significant difference from the B-CB-P group
(P <0.05). (G, H) Quantitative analysis of collagen and sGAG content of constructs at the fourth week postoperatively. (I, J) Quantitative analysis of collagen
and sGAG content of constructs at the 12th week postoperatively. *P <0.05, B-CB-P group versus B-C-P group, or native cartilage. B-C-P,
BMSCs–chondrocytes–PRP; B-CB-P, BMSCs–cell bricks–PRP; B-P, BMSCs–PRP; BMSC, bone marrow-derived mesenchymal stem cell; Col, collagen;
PRP, platelet-rich plasma; sGAG, sulfated glycosaminoglycan.
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group (32.0 ± 2.7 vessels/high power field vs. 15.0 ± 1.2
vessels/high power field, P <0.05) (Figure 6E). These data
showed that the chondrogenic BMSCs resisted later
hypertrophy and prevented angiogenesis-mediated endo-
chondral ossification.
We further performed immunostaining and real-time
RT-PCR to analyze expression of VEGF, which is known
as a key component to induce angiogenesis. In accordance
with angiogenesis in BMSC regions, the B-CB-P group
and B-C-P group both expressed moderate VEGF since
the fourth week (Figure 6F). Interestingly, VEGF was sig-
nificantly decreased with longer in vivo incubation in the
B-CB-P group (Figure 6F), which was completely different
from endochondral ossification occurring in B-C-P sam-
ples (Figure 6F), and also explained why angiogenesis was
inhibited through 12 weeks. Real-time RT-PCR confirmed
the expression of VEGF in BMSC regions of constructs.
Even though the expression of VEGF was significantly
higher than that of native auricular, the expression of
VEGF decreased in B-CB-P at the 12th week compared
with the fourth week, which was just opposite to the re-
sults of the B-C-P group (Figure 6G, P <0.05). At the 12th
week, BMSCs in the B-C-P group displayed higher expres-
sion of VEGF than B-CB-P samples (Figure 6G, P <0.05).
Moreover, there was no significant difference in the ex-
pression of VEGF in the B-CB-P group and native auricu-
lar cartilage at the 12th week.
B-CB-P grafts enabled stable nasal augmentation in vivo
To test whether the B-CB-P complex could resist exter-
nal pressure and could be applied for craniofacial recon-
struction, nasal augmentation was performed using such
an approach in nude mice. After 300 μl gel-like B-CB-P
complex was injected subcutaneously into nasal dorsum,
the skin was significantly elevated and gelling substancesfilled the subcutaneous cavity according to the customized
nasal morphology. Slight volume reduction could be ob-
served during the further in vivo remodeling process,
which resulted in significant augmentation of the nasal
dorsum (Figure 7A,B,C). After 12 weeks, the injected con-
structs turned into resilient, nasal ridge-like cartilage
tissues (Figure 7D). H & E staining revealed BMSCs in
constructs merged with chondrocyte bricks and most cells
were embedded in a lacuna structure. Furthermore,
safranin-O staining showed that most of constructs turned
into glycosaminoglycan-enriched ECM, and COL-II im-
munostaining further confirmed that the type II collagen
was widely expressed in ECM. Masson’s trichrome stain-
ing revealed no calcification and ossification were ob-
served in samples (Figure 7E,F,G,H,I,J,K,L). These results
demonstrated that B-CB-P grafts could be adapted into a
customized morphology during the injecting process as
well as later in vivo remodeling, therefore supporting re-
generation of nasal cartilaginous tissue in craniofacial
regions.
Discussion
Developing an injectable approach for cartilage regeneration
could meet today’s demand for micro-invasive surgery [19].
Different from solid scaffold-based tissue engineering, inject-
able cartilage constructs require fluidity of components and
instant establishment of a chondrogenic niche for BMSCs,
which is challenging for scaffold design. We have proved
that fragmented chondrocyte macroaggregates (cell bricks)
could stabilize the PRP gel efficiently in vivo and support
chondrogenesis with stable morphology [17]. In this study,
for the first time, we found that such an injectable complex
could support chondrogenesis of BMSCs in vivo, and dem-
onstrated that such a completely biological graft could meet
the requirement of nasal augmentation, thus holding future
promise in craniofacial reconstruction. The characterization
Figure 6 Angiogenesis regulated by cell bricks prevented central necrosis and ossification of constructs. Evaluation of angiogenesis in B-CB-P grafts
at the fourth week and 12th week. (A, C) Histological images reveal infiltration of capillaries at the fourth week and 12th week, predominantly distributed in
BMSC regions, as confirmed by CD31 immunofluorescent staining (B, D). (E) Comparison of the number of blood vessels between the fourth week and 12th
week as described previously; the value represents the cumulative number of all slides examined (n= 8). The fourth-week grafts allowed more blood vessel
formation than those in the 12th week. (F) Immunostaining of vascular endothelial growth factor (VEGF) revealed decreasing expression of VEGF in BMSC
regions through 4 and 12 weeks in the B-CB-P group, but increasing expression in the B-C-P group. Positive control, native cancellous bone; negative control,
native auricular cartilage; bar = 50 μm, magnification × 100. (G) Real-time RT-PCR revealed the expression of VEGF in the B-CB-P and B-C-P groups, which were
all normalized to rabbit auricular cartilage. *Statistically significant difference from rabbit auricular cartilage (P <0.05). #Statistically significant difference
from the B-CB-P group (P <0.05).▲Statistically significant difference of each group at two time points. B-C-P, BMSCs–chondrocytes–PRP; B-CB-P,
BMSCs–cell bricks–PRP; B-P, BMSCs–PRP; BMSC, bone marrow-derived mesenchymal stem cell; HE, hematoxylin and eosin; HFP, high power field; PRP,
platelet-rich plasma.
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that brick-like chondrocytes–ECM complex could be
smoothly injected and formulated PRP gel into multiple
units; such enclosed spaces provided a chondrogenic niche
for BMSCs. Further in vivo results revealed that the cartil-
aginous ECM in cell bricks provided adequate intrinsic re-
sistance to surrounding pressure, and found that B-CB-P
graft enabled morphological maintenance in a subcutaneous
and even nasal dorsum environment, thus providing a novel
and efficient strategy for cell transplantation. In contrast,
mixing chondrocytes with BMSCs directly underwent sig-
nificant contraction during in vivo remodeling, which could
be ascribed to slow ECM formation and rapid degradation
of PRP. These findings highlight the importance of cellbricks to establish injectable cell microenvironments for
chondrogenesis of BMSCs in vivo.
Preventing ossification of BMSCs represents a critical
step towards clinical translation of BMSCs in cartilage tis-
sue engineering [20]. The most important finding in this
study is that BMSCs embedded in chondrocyte brick-
enriched PRP gel underwent persistent chondrogenesis,
and hypertrophic translation was prevented. Coculturing
mature chondrocytes and BMSCs has been shown to sig-
nificantly reduce hypertrophic potential of BMSCs and
support neocartilage development in vivo [21]. Paracrine
signaling of soluble chondrogenic factors provided by
chondrocytes was an important mechanism in directing
the in vivo ectopic chondrogenesis of BMSCs [10,22]. It is
Figure 7 B-CB-P grafts enabled stable nasal augmentation in vivo. (A to D) Nasal augmentation regenerated by cell brick-enriched PRP gel
composited with BMSCs. (E to H) Histological analysis including HE, safranin-O, Masson’s trichrome staining and COL-II immunostaining of the
cross-sections further revealed that the samples formed homogeneous cartilage-like tissue with abundant lacunae as well as strong positive
staining of GAG and type II collagen without ossification, and higher magnification for the above staining (I to L); bar = 200 μm, magnification
× 40 (E to H) and bar = 50 μm, magnification × 200 (I to L). B-CB-P, BMSCs–cell bricks–PRP; BMSC, bone marrow-derived mesenchymal stem cell;
COL, collagen; HE, hematoxylin and eosin; PRP, platelet-rich plasma; GAG, glycosaminoglycan.
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angiogenic factors such as endostatin and chondromodulin I
[15,16]. Previous coimplantation of BMSCs and chondro-
cytes frequently requires solid scaffold-based cell incubation
prior to in vivo transplantation, so that cartilaginous ECM
could be produced to constitute the enclosed niche for
BMSCs before in vivo remodeling was initiated [23]. Inter-
estingly, we found direct mixing of chondrocytes and
BMSCs with PRP could delay the endochondrial ossification
of BMSCs, whereas it failed to prevent final ossification. In
vivo results showed that endochondral ossification started
from BMSCs adjacent to surrounding host tissues. We sus-
pected that the opening microenvironment caused by fast
degradation of peripheral PRP failed to retain paracrine
factors released from chondrocytes, which resulted in pro-
gressive ossification of BMSCs. Different from the opening
structure in the B-C-P group, chondrocyte bricks reconsti-
tuted PRP into multiple cavities and further merged into
enclosed ECM shell for graft at the 12th week; such anenclosed cartilaginous microenvironment definitely pro-
tected BMSCs from intervention surrounding the host
microenvironment and activation of endochondral ossifica-
tion. This finding warranted reduction of the donor cartilage
as compared with conventional chondrocyte transplantation,
and provide a micro-invasive approach for cartilage regener-
ation, indicating the promising future of cell bricks for clin-
ical application. For clinical translation, donor cartilage
could be harvested from the nasal septum, part of the aur-
icle, nonloading articular surface and residual cartilage from
microtia. Additionally, we are exploring the possibility of
acellular chondrocyte sheets in inducing chondrogenesis of
BMSCs, so that heterogeneous chondrocytes could be used
for achieving cell bricks that may release donors thoroughly
in the future.
Blood vessel invasion is a requisite aspect of endochondral
ossification; on the other hand, adequate vascularization is
critical for nutritional perfusion and tissue survival [18,24].
The important advantage of PRP gel is that it could initiate
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late the wound healing process. A surprising phenomenon
presented in our study is that BMSCs mixed into CB-PRP
gel guided fast angiogenesis in BMSC regions and prevented
central necrosis of the whole graft. Our previous experiment
encountered the problem that chondrocytes mixed into CB-
PRP gels resulted in obvious necrosis in the interior of
constructs, which could be attributed to the robust anti-
angiogenic potential of chondrocytes [20,25]. BMSCs, espe-
cially those stimulated by a hypoxia environment, convey
essential angiogenic signals including VEGF, matrix metal-
loproteinase 9, stromal cell-derived factor 1 and granulocyte
macrophage colony–stimulating factor [26-28], and VEGF
is the most important mediator of angiogenesis, which cou-
ples recruitment of endothelial cells, capillary infiltration
and ossification of hypertrophic cartilage [29-31]. Our re-
sults confirmed that BMSCs in CB-PRP gels presented
higher VEGF expression than chondrocytes in CB-PRP gels,
which was regarded to contribute the angiogenesis in
BMSC regions in PRP grafts. This finding also indicated
that B-CB-P grafts are superior to the previous cell–solid
scaffold approach because they avoided the poor nutritional
perfusion in central regions. Furthermore, our study
revealed that the early angiogenesis of BMSC regions in B-
CB-P grafts did not resulted in hypertrophy of chondro-
genic BMSCs. The C-CB-P group in our previous study
[17] and the B-CB-P group in this study both expressed
type I and type X collagen; however, expression of these
proteins was at a very low level. In this study, real-time RT-
PCR confirmed that the gene expression of type I and type
X collagen in the B-CB-P group was obviously lower than
other groups, which demonstrated the inhibited hyper-
trophy in this group. From 4 to 12 weeks, B-CB-P grafts
presented decreasing VEGF, and the amount of capillaries
significantly decreased in BMSCs with the chondrogenic
differentiation of BMSCs. In contrast, progressive ossifi-
cation of BMSCs in B-C-P and B-P grafts presented
hypertrophic makers such as Col-X and increasing
vascularization. Although the further mechanism
remained to be unraveled, this finding indicated that
chondrocyte bricks interrupted angiogenesis-mediated
endochondral ossification, which played a key role in
realizing the persistence of chondrogenic differentiation
of BMSCs.
GAG and collagen production are related to the mechan-
ical properties of cartilage. In our study, although the 12-
week results presented cartilage formation in BMSC regions,
safranin-O staining and COL-II staining indicated that the
cartilaginous matrices formed by chondrogenic BMSCs are
still less than those of chondrocytes. Quantification of the
ECM also confirmed our observation. These results indi-
cated that chondrogenic differentiation of BMSCs in B-CB-
P grafts is still insufficient. Owing to the lifespan of the nude
mice, whether longer in vivo development will allow betterchondrogenesis remains to be investigated. Further study
will use autologous cell transplantation in a rabbit model so
that long-term results for 6 months to 1 year could be evalu-
ated. The other possible reason for insufficient chondrogen-
esis may be too much distance between BMSCs and
chondrocyte bricks. Different from direct mixing of cells,
gaps between BMSCs and chondrocyte bricks will weaken
the paracrine signals released from cell bricks. The size of
cell bricks should therefore be optimized further in studies
so that adequate distribution could be acquired.
Conclusion
The findings reported here provided a novel, efficient and
injectable approach to regenerate cartilage tissues in vivo.
Compared with chondrocytes, chondrocyte bricks could
maintain the graft morphology in vivo, enable cartilage re-
pair with specific shape, and persistently prevent hyper-
trophic transition of BMSCs in vivo. On the other hand,
BMSCs interacted with cell bricks and mediated early vas-
culogenesis in the interior of graft, which warranted the
survival of interior cells and chondrogenesis of whole
grafts.
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